Cargando…
Alternative Splicing Programs in Prostate Cancer
Prostate cancer (PCa) remains one of the most frequent causes of death for cancer in the male population. Although the initial antiandrogenic therapies are efficacious, PCa often evolves into a hormone-resistant, incurable disease. The genetic and phenotypic heterogeneity of this type of cancer rend...
Autor principal: | Sette, Claudio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747374/ https://www.ncbi.nlm.nih.gov/pubmed/23983695 http://dx.doi.org/10.1155/2013/458727 |
Ejemplares similares
-
Phosphorylation-Mediated Regulation of Alternative Splicing in Cancer
por: Naro, Chiara, et al.
Publicado: (2013) -
Alternative Splicing: Role in Cancer Development and Progression
por: Sette, Claudio, et al.
Publicado: (2013) -
EMT and stemness: flexible processes tuned by alternative splicing in development and cancer progression
por: Pradella, Davide, et al.
Publicado: (2017) -
FOXA1 regulates alternative splicing in prostate cancer
por: Del Giudice, Marco, et al.
Publicado: (2022) -
Non-Canonical Splicing and Its Implications in Brain Physiology and Cancer
por: Pitolli, Consuelo, et al.
Publicado: (2022)